View on Pubmed.gov 25371669 | View on doi.org 10.1155/2014/13...
COX-2 Inhibitors and Gastric Cancer.
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Abstract
The evidence that cyclooxygenase-2 (COX-2) is upregulated and plays an important role in carcinogenesis of gastric cancer has triggered the topic of COX-2 inhibitors as chemopreventive agents for gastric cancer. Studies find that COX-2 inhibitors are associated not only with chemoprophylactic effects, but also with chemotherapeutic potentials in gastric cancer. Both COX-dependent and COX-independent pathways have a role in the anticancer efficiency of COX-2 inhibitors. However, enthusiasm is thwarted by the potential toxicity, that is, gastrointestinal toxicity of nonselective COX-2 inhibitors and cardiovascular risk of selective COX-2 inhibitors. Therefore, more studies are needed to develop new targeted antitumor agents (such as prostaglandin E receptor antagonist) and to define fundamental questions such as optimal treatment regimens, integration of cotherapy, and careful selection of candidates.
References
Ann Oncol. 2012 Jun;23(6):1403-15
Curr Pharm Des. 2013;19(1):115-25
World J Gastroenterol. 2004 Oct 1;10(19):2809-13
Cancer Lett. 2007 Jun 28;251(2):268-77
Cited by 47 citations (total)
Journal Article Research Support, Non-U.S. Gov't
Dietary n-3 and n-6 polyunsaturated fatty acids, the FADS gene, and the risk of gastric cancer in a Korean population.
Electronic publication date September 17, 2019
Sunghee Lee [...] Jeongseon Kim et al.
n-3 polyunsaturated fatty acids (PUFAs) and n-6 PUFAs are reported to have immunomodulatory effects, but few studies have examined these...
Journal Article Meta-Analysis
Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
Electronic publication date February 20, 2018
Xuan-Zhang Huang [...] Wen-Jun Chen et al.
BACKGROUND
The association between non-steroidal anti-inflammatory drugs (NSAIDs) and gastric cancer (GC) risk is controversial. The aim of this study is...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
- •
- •